Afya Limited (NASDAQ:AFYA) Q2 2021 Earnings Conference Call August 26, 2021 5:00 PM ET Company Participants Renata Costa Couto – Director-Investor Relations Virgilio Gibbon – Chief Executive Officer Luis Andre Blanco – Chief Financial Officer Júlio De Angeli – Vice President of Innovation Conference Call Participants Marcelo Santos – J.P. Morgan Javier Martinez – Morgan Stanley Mauricio Cepeda – Credit Suisse Vinicius Ribeiro – UBS Renata Costa Couto Thank you for joining us for Afya's Second Quarter 2021 ...

Afya Limited (NASDAQ:AFYA) Q1 2021 Earnings Conference Call May 28, 2021 11:00 AM ET Company Participants Renata Couto - Head of Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Gabriel Martinez - JPMorgan Caio Moscardini - Morgan Stanley Vitor Tomita - Goldman Sachs Mauricio Cepeda - Credit Suisse Lucca Brendim - Bradesco BBI Renata Couto [Call starts abruptly] for Afya's First Quarter 2021 Conference Call. With me on the ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 19 ...

Afya Limited (NASDAQ:AFYA) Q4 2020 Results Conference Call April 9, 2021 11:00 AM ET Company Participants Renata Couto - Head of Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Julio de Angeli - Vice President of Innovation and Continuing Medical Education Conference Call Participants Marcelo Santos - JPMorgan Thiago Bortoluci - Goldman Sachs Caio Moscardini - Morgan Stanley Vinicius Ribeiro - UBS Renata Couto Good morning, everyone. Thank you for jo ...

Financial Data and Key Metrics Changes - Adjusted net revenue for Q3 2020 increased by 52% year over year to BRL 313 million, primarily due to the maturation of medical school seats and consolidation of acquired companies [9][19] - Adjusted EBITDA increased by 63% to BRL 149 million, with a margin expansion of 340 basis points [20] - Net income rose by 47% to BRL 101 million, with earnings per share increasing by 48% from BRL 0.54 to BRL 0.80 [10][21] - Cash and cash equivalents at the end of the quarter were approximately BRL 1.1 billion, reflecting strong cash flow generation [10][27] Business Line Data and Key Metrics Changes - The number of medical seats increased by 294 year over year, totaling 1,516 seats [18] - The total number of students reached 9,567, a 50% increase compared to the same period last year [19] - Average monthly medical tuition fees increased by 17% to BRL 8,053, contributing to a 41% rise in net tuition fees year over year [21][22] Market Data and Key Metrics Changes - 78% of combined tuition fees were derived from medical schools, up from 69% in the same period of the prior year [22] - Active paying users reached 130,000 at the quarter end, including 95,000 from PEBMED, with a 40% increase in active paying students excluding PEBMED [22] Company Strategy and Development Direction - The company aims to maintain long-term relationships with physicians from their entry into medical school through their entire career, focusing on digital health products and medical programs [16] - The company is committed to disciplined acquisitions to further grow its digital assets and enhance its service offerings [17][56] - Recent acquisitions in digital health services, including PEBMED, iClinic, and MedPhone, are expected to strengthen the company's position in the health tech segment [11][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strong cash flow and healthy balance sheet to navigate through the challenges posed by COVID-19 [10][17] - The company anticipates maintaining a 100% occupancy rate for medical seats in 2021, with no surprises expected in the intake [34] - Management acknowledged the impact of COVID-19 on traditional on-campus programs but remains focused on sustainable operations [45] Other Important Information - The company won awards in the education sector, recognizing its leadership in financials, corporate governance, and sustainability [12] - The company reaffirmed its second-half 2020 guidance, expecting net revenue between BRL 600 million and BRL 640 million [30] Q&A Session Summary Question: Update on the intake for the medical unit in 2021 - Management indicated a positive trend for 2021 intake, expecting 100% occupancy of all seats [34] Question: PEBMED integration and cross-sell initiatives - Integration activities are ongoing, with commercial activities promoting both PEBMED and Medcel products [35] Question: Plans for MedPhone and WhiteBook - Both applications will be maintained, with a focus on converting MedPhone users to WhiteBook subscribers [39] Question: Discounts recognized in the quarter - All mandatory discounts for Q3 have been recognized, with expectations of 1% to 2% of net revenues in Q4 [44] Question: Non-medical programs and their future - The company is closing non-sustainable programs, focusing on maintaining high margins and operational efficiency [45][46] Question: Receivables and cash flow insights - Receivables increased due to lower student advances and financial support during the pandemic, but are expected to decrease moving forward [49] Question: Dropouts and M&A perspective - Management noted no significant increase in dropouts and remains disciplined in pursuing M&A opportunities [53][56]

Afya Limited (NASDAQ:AFYA) Q2 2020 Earnings Conference Call August 28, 2020 11:00 AM ET Company Participants Renata Couto – Head-Investor Relations Virgilio Gibbon – Chief Executive Officer Luis André Blanco – Chief Financial Officer Julio Eduardo – Vice President of Innovation and Continuing Medical Education Conference Call Participants Marcelo Santos – Banco JPMorgan Mauricio Cepeda – Credit Suisse Irma Sgarz – Goldman Sachs Susana Salaru – Itau Vinicius Ribeiro – UBS Operator Good morning, ladies and ge ...